[go: up one dir, main page]

Shacter et al., 1991 - Google Patents

Inhibition of the myeloperoxidase-H2O2-Cl− system of neutrophils by indomethacin and other non-steroidal anti-inflammatory drugs

Shacter et al., 1991

Document ID
468648584187780583
Author
Shacter E
Lopez R
Pati S
Publication year
Publication venue
Biochemical pharmacology

External Links

Snippet

The results presented herein demonstrate that the non-steroidal anti-inflammatory drug (NSAID) indomethacin is a strong inhibitor of the formation of HOCl by murine neutrophils (50% inhibition at 15 μM). Addition of 40 μM indomethacin to activated neutrophils caused …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/573—Immunoassay; Biospecific binding assay for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Similar Documents

Publication Publication Date Title
Shacter et al. Inhibition of the myeloperoxidase-H2O2-Cl− system of neutrophils by indomethacin and other non-steroidal anti-inflammatory drugs
Jaouad et al. Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydyl groups
Pereira et al. Oxidative stress and DNA damage: implications in inflammatory bowel disease
Hampton et al. Involvement of superoxide and myeloperoxidase in oxygen-dependent killing of Staphylococcus aureus by neutrophils
Gil et al. Contribution to characterization of oxidative stress in HIV/AIDS patients
Dahlgren et al. Measurement of respiratory burst products generated by professional phagocytes
Ewing et al. Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator
Dahlgren et al. Respiratory burst in human neutrophils
Sipos et al. Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminals
Rehman et al. Scavenging of hydroxyl radicals but not of peroxynitrite by inhibitors and substrates of nitric oxide synthases
Rusanova et al. Oxidative stress status, clinical outcome, and β‐globin gene cluster haplotypes in pediatric patients with sickle cell disease
Lesgards et al. Effect of reactive oxygen and carbonyl species on crucial cellular antioxidant enzymes
Ozgocmen et al. In vivo effect of celecoxib and tenoxicam on oxidant/anti-oxidant status of patients with knee osteoarthritis
A Kosenko et al. Relationship between chronic disturbance of 2, 3-diphosphoglycerate metabolism in erythrocytes and Alzheimer disease
Ali et al. Catalase prevents myeloperoxidase self-destruction in response to oxidative stress
Boldyrev et al. Sources of reactive oxygen species production in excitotoxin-stimulated cerebellar granule cells
Pich et al. Inhibitor sensitivity of respiratory complex I in human platelets: a possible biomarker of ageing
Jeelani et al. Mesna (2-mercaptoethane sodium sulfonate) functions as a regulator of myeloperoxidase
US7108997B2 (en) Assay for detecting inhibitors of the enzyme myeloperoxidase
Han et al. NAD (P) H: quinone oxidoreductase-1-dependent and-independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors
Fedotcheva et al. Substrate-specific reduction of tetrazolium salts by isolated mitochondria, tissues, and leukocytes
Sethi et al. Nitric oxide-and oxygen-derived free radical generation from control and lipopolysaccharide-treated rat polymorphonuclear leukocyte
EP1387893B1 (en) An assay for detecting inhibitors of the enzyme myeloperokidase
Kunsch et al. Oxidative stress and the use of antioxidants for the treatment of rheumatoid arthritis
Kumar et al. Antioxidant enzymes in rheumatoid arthritis